The Place of Adoption in the NIDA Clinical Trials Network.

Journal of Drug Issues
Martha JessupBarbara Tajima

Abstract

The National Institute on Drug Abuse (NIDA) Clinical Trials Network (CTN) was established in 1999 to determine effectiveness of drug abuse treatment interventions among diverse client populations and settings. To address dissemination of research findings, the CTN also has as its mission the transfer of research findings to treatment providers. In a qualitative study of adoption of evidence based practice in the context of two CTN clinical trials, we interviewed 29 participants from seven organizational levels of the multisite study organization about post-trial adoption, their role in the clinical trial, and interactions between the research initiative and clinic staff and setting. Analysis of interview data revealed a range of opinion among participants on the place of adoption within the CTN. Innovation within the CTN to support adoption and further observational research on dynamics of adoption within the CTN can increase dissemination of evidence-based drug abuse treatment interventions in the future.

References

Jan 4, 2001·Substance Use & Misuse·J Morgenstern
Aug 23, 2001·Journal of Substance Abuse Treatment·R F FormanG Woody
Jan 1, 1995·Science and Engineering Ethics·Wolfgang BenderKristina Sinemus
Aug 6, 2002·Psychiatric Services : a Journal of the American Psychiatric Association·Patricia Marinelli-CaseyRichard A Rawson
Mar 1, 2003·Psychiatric Services : a Journal of the American Psychiatric Association·Kathleen M Carroll, Bruce J Rounsaville
Jun 18, 2003·Journal of Substance Abuse Treatment·Steven L GallonJeffrey R W Knudsen
Dec 31, 2003·Journal of Substance Abuse Treatment·Hannah K Knudsen, Paul M Roman
Apr 6, 2004·Journal of Substance Abuse Treatment·Dennis McCartyJeff Knudsen
Apr 16, 2004·The American Journal of Drug and Alcohol Abuse·Kathleen A MooreThomas W Valente
Feb 23, 2005·Journal of Substance Abuse Treatment·Theresa B MoyersWilliam R Miller
Sep 20, 2005·Drug and Alcohol Dependence·Kathleen M CarrollUNKNOWN National Institute on Drug Abuse Clinical Trials Network
Dec 27, 2005·Drug and Alcohol Dependence·Nancy M PetryJohn A Hamilton
Feb 20, 2007·Journal of Substance Abuse Treatment·Joseph GuydishMartha Jessup
May 8, 2007·Journal of Substance Abuse Treatment·Lori J DucharmeJ Aaron Johnson
Sep 21, 2007·The American Journal on Addictions·Hannah K KnudsenPaul M Roman
Jun 17, 2008·Science & Practice Perspectives·Dennis McCartyMerwyn R Greenlick
Jan 1, 1994·Qualitative Sociology·Ali ManwarEloise Dunlap
Jul 1, 2005·Journal of Drug Issues·J GuydishT Montini

❮ Previous
Next ❯

Citations

Dec 9, 2010·Journal of Psychoactive Drugs·Joseph GuydishSarah Turcotte Manser
Jul 23, 2010·Journal of Psychoactive Drugs·Philip R LeeM Arch
Apr 15, 2010·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Yifrah KaminerDaniel F Connor

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.